Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Shares Outstanding (Diluted Average): 2021-2025

Historic Shares Outstanding (Diluted Average) for Krystal Biotech (KRYS) over the last 5 years, with Sep 2025 value amounting to $29.8 million.

  • Krystal Biotech's Shares Outstanding (Diluted Average) fell 0.23% to $29.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.8 million, marking a year-over-year decrease of 0.23%. This contributed to the annual value of $29.7 million for FY2024, which is 7.16% up from last year.
  • Per Krystal Biotech's latest filing, its Shares Outstanding (Diluted Average) stood at $29.8 million for Q3 2025, which was up 0.05% from $29.8 million recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Shares Outstanding (Diluted Average) registered a high of $29.9 million during Q3 2024, and its lowest value of $21.3 million during Q1 2021.
  • Over the past 3 years, Krystal Biotech's median Shares Outstanding (Diluted Average) value was $29.6 million (recorded in 2024), while the average stood at $28.8 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first rose by 18.17% in 2022, then declined by 0.23% in 2025.
  • Krystal Biotech's Shares Outstanding (Diluted Average) (Quarterly) stood at $22.2 million in 2021, then rose by 14.85% to $25.5 million in 2022, then climbed by 8.87% to $27.8 million in 2023, then climbed by 7.16% to $29.7 million in 2024, then dropped by 0.23% to $29.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $29.8 million for Q3 2025, versus $29.8 million for Q2 2025 and $29.9 million for Q1 2025.